Vision restored with total darkness

Restoring vision might sometimes be as simple as turning out the lights. That's according to a study reported on February 14 in Current Biology, a Cell Press publication, in which researchers examined kittens with a visual ...

Feb 14, 2013
popularity0 comments 1

Amblyopia, also known as lazy eye, is a disorder of the visual system that is characterized by a vision deficiency in an eye that is otherwise physically normal, or out of proportion to associated structural abnormalities of the eye. It has been estimated to affect 1–5% of the population.

Amblyopia means that visual stimulation either fails to transmit or is poorly transmitted through the optic nerve to the brain for a continuous period of time. It can also occur when the brain "turns off" the visual processing of one eye, to prevent double-vision, for example in strabismus (crossed-eyes). It often occurs during early childhood, resulting in poor or blurry vision. Amblyopia normally affects only one eye in most patients. However, it is possible, though rare, to be amblyopic in both eyes, if both fail to receive clear visual images. Detecting the condition in early childhood increases the chance of successful treatment, especially if detected before the age of five. The earlier it is detected, and the underlying cause corrected with spectacles and/or surgery, the more successful the treatment in equalizing vision between the two eyes.

The colloquialism "lazy eye" is frequently used to refer to amblyopia. The term "lazy eye" is imprecise because it is a layman's term for strabismus, particularly exotropia.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

Researchers grow retinal nerve cells in the lab

Johns Hopkins researchers have developed a method to efficiently turn human stem cells into retinal ganglion cells, the type of nerve cells located within the retina that transmit visual signals from the eye to the brain. ...

Researchers find sleep gene linked to heart failure

Researchers at the Stanford University School of Medicine have identified a gene that, when working properly, appears to reduce the risk of heart failure and improve treatment outcomes, highlighting a possible target for ...